Contact

About
Food Allergies and Our Approach
- Food Allergies Overview
- Our Approach and Platform
Programmes and Clinical Trials
News & Events
- News
- Events
- In the News
Menu Menu

Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

21 May 2024

Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

SnackSafely.com
21 May 2024

https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png 0 0 axergy https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png axergy2024-05-21 08:00:502026-02-05 15:01:45Aravax’s Phase 2 Study Now Enrolling Children with Peanut Allergy

© Aravax

Contact Us

Email: info@aravax.com.au

Australia

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia
Tel: +61 (0)3 9657 0700

UK

John Eccles House, Oxford Science Park
Oxford, OX4 4GP, United Kingdom

Aravax Appoints Dr Paul Laidler as VP Pharmaceutical Development Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy...